C329-0431 Screening compound: 2-cyclopentyl-N-(9-ethyl-9H-carbazol-3-yl)-9-methyl-1-oxo-1H,2H,9H-pyrido[3,4-b]indole-4-carboxamide

C329-0431 Screening compound: 2-cyclopentyl-N-(9-ethyl-9H-carbazol-3-yl)-9-methyl-1-oxo-1H,2H,9H-pyrido[3,4-b]indole-4-carboxamide
C329-0431 Screening compound: 2-cyclopentyl-N-(9-ethyl-9H-carbazol-3-yl)-9-methyl-1-oxo-1H,2H,9H-pyrido[3,4-b]indole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C329-0431
2-cyclopentyl-N-(9-ethyl-9H-carbazol-3-yl)-9-methyl-1-oxo-1H,2H,9H-pyrido[3,4-b]indole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C329-0431

Molecular Formula

C32H30N4O2 (C32 H30 N4 O2)

Compound Name

2-cyclopentyl-N-(9-ethyl-9H-carbazol-3-yl)-9-methyl-1-oxo-1H,2H,9H-pyrido[3,4-b]indole-4-carboxamide

IUPAC name

2-cyclopentyl-N-(9-ethyl-9H-carbazol-3-yl)-9-methyl-1-oxo-1H2H9H-pyrido[34-b]indole-4-carboxamide

SMILES

CCn1c(ccc(NC(C(c2c3n(C)c4c2cccc4)=CN(C2CCCC2)C3=O)=O)c2)c2c2c1cccc2

InChI

InChI=1S/C32H30N4O2/c1-3-35-27-15-9-6-12-22(27)24-18-20(16-17-28(24)35)33-31(37)25-19-36(21-10-4-5-11-21)32(38)30-29(25)23-13-7-8-14-26(23)34(30)2/h6-9,12-19,21H,3-5,10-11H2,1-2H3,(H,33,37)

InChI Key

UYFBBUISDKKSTH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14749037

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

502.62

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.121

Distribution Coefficient, logD

6.121

Water Solubility, LogSw

-5.69

Polar Surface Area

41.668

Acid Dissociation Constant (pKa)

11.91

Base Dissociation Constant (pKb)

-0.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

C329-0431 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Lipid Metabolism Library (9174 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cardiovascular
  • Metabolic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C329-0431 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C329-0431?
Check Price and Availability of C329-0431, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C329-0431 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C329-0431
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C329-0431
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C329-0431 available by request